Cargando…
Mesenchymal Stem Cell-Derived Exosomal Noncoding RNAs as Alternative Treatments for Myocardial Ischemia-Reperfusion Injury: Current Status and Future Perspectives
Ischemic cardiomyopathy is treated mainly with thrombolytic drugs, percutaneous coronary intervention, and coronary artery bypass grafting to recanalize blocked vessels. Myocardial ischemia-reperfusion injury (MIRI) is an unavoidable complication of obstructive revascularization. Compared with those...
Autores principales: | Chang, Chen, Cai, Ru-Ping, Su, Ying-Man, Wu, Qiang, Su, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246878/ https://www.ncbi.nlm.nih.gov/pubmed/37286924 http://dx.doi.org/10.1007/s12265-023-10401-w |
Ejemplares similares
-
Long Noncoding RNAs in Myocardial Ischemia-Reperfusion Injury
por: Zhao, Zhuo, et al.
Publicado: (2021) -
Exosomes in Cerebral Ischemia-Reperfusion Injury: Current Perspectives and Future Challenges
por: Zhou, Chao, et al.
Publicado: (2022) -
Inhibition of Myocardial Ischemia/Reperfusion Injury by Exosomes Secreted from Mesenchymal Stem Cells
por: Zhang, Heng, et al.
Publicado: (2016) -
Cell Death and Exosomes Regulation After Myocardial Infarction and Ischemia-Reperfusion
por: Wu, Xun, et al.
Publicado: (2021) -
From cerebral ischemia towards myocardial, renal, and hepatic ischemia: Exosomal miRNAs as a general concept of intercellular communication in ischemia-reperfusion injury
por: Xin, Wenqiang, et al.
Publicado: (2022)